Company: GCL
Filing Date: 2025-04-03
Form Type: F-1
Source: 0001213900-25-028608
Chunk: 39

Company: GCL Global Holdings Ltd
Filing Date: 2025-04-03
Form: F-1
Chunk 39
---
 and other business restrictions adopted by us and imposed
by various governments in response to the COVID-19 pandemic or other future health epidemics or contagious disease outbreaks, we may encounter
challenges in evaluating future acquisitions, investments, and joint ventures and integrating personnel, business practices, and company
cultures from acquired companies. Acquisitions, investments, and joint ventures could result in potential dilutive issuances of equity
securities, use of significant cash balances or incurrence of debt (and increased interest expense), contingent liabilities or amortization
expenses related to intangible assets, or write-offs of goodwill or intangible assets, which could adversely affect our results of operations
and dilute the economic and voting rights of our stockholders.

We plan to raise additional funds through sale of equity or convertible debt securities in order to fuel business growth.

To fuel the growth of our
business, we plan to raise financing through sale of equity or convertible debt securities in the near future. However, there is no assurance
that such financing will be available to us when needed, or if available, on terms that are favorable to us. Should the financing we require
be unavailable to us, or on terms unacceptable to us when we require it, we may have to delay, curtail or alter our strategic acquisition
or business plans, and as a result, our business, operating results, financial condition, and prospects could be materially adversely
affected.

The price per share at which
we sell additional Ordinary Shares or securities convertible into our Ordinary Shares in future transactions may be higher or lower than
the price per share paid to the Selling Shareholders. The terms of any securities issued by us in future capital transactions may be more
favorable to new investors, and may include preferences, superior voting rights and the issuance of warrants or other derivative securities,
which may have a further dilutive effect on the holders of any of our securities then outstanding. In addition, we may incur substantial
costs in pursuing future capital financing, including investment banking fees, legal fees, accounting fees, securities law compliance
fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash expenses in connection with certain
securities we issue, such as convertible notes and warrants, which may adversely impact our financial condition.

We are or may be subject to contractual covenants which place certain limitations on how we manage our business.

Certain credit agreements we
have with banks (the “Credit Agreement”) may limit our ability to take various actions, including in